Genpact Limited
G · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4,767 | $4,477 | $4,371 | $4,022 |
| % Growth | 6.5% | 2.4% | 8.7% | – |
| Cost of Goods Sold | $3,077 | $2,906 | $2,835 | $2,590 |
| Gross Profit | $1,690 | $1,571 | $1,536 | $1,432 |
| % Margin | 35.5% | 35.1% | 35.1% | 35.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $967 | $913 | $938 | $866 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21 | $27 | $96 | $57 |
| Operating Expenses | $988 | $940 | $1,034 | $923 |
| Operating Income | $702 | $631 | $502 | $509 |
| % Margin | 14.7% | 14.1% | 11.5% | 12.7% |
| Other Income/Exp. Net | -$25 | -$29 | -$37 | -$26 |
| Pre-Tax Income | $677 | $602 | $465 | $483 |
| Tax Expense | $163 | -$29 | $112 | $114 |
| Net Income | $514 | $631 | $353 | $369 |
| % Margin | 10.8% | 14.1% | 8.1% | 9.2% |
| EPS | 2.88 | 3.46 | 1.92 | 1.97 |
| % Growth | -16.8% | 80.2% | -2.5% | – |
| EPS Diluted | 2.85 | 3.41 | 1.88 | 1.91 |
| Weighted Avg Shares Out | 178 | 182 | 184 | 188 |
| Weighted Avg Shares Out Dil | 180 | 185 | 188 | 193 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32 | $18 | $6 | $7 |
| Interest Expense | $80 | $66 | $58 | $58 |
| Depreciation & Amortization | $96 | $104 | $130 | $168 |
| EBITDA | $853 | $773 | $653 | $709 |
| % Margin | 17.9% | 17.3% | 14.9% | 17.6% |